From: Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma
Multivariate
HR (95% CI)
P value
MMRN1
1.15 (0.94–1.40)
0.179
ABCB5
1.24 (1.09–1.40)
0.001
XG
1.28 (1.09–1.51)
0.003
FAM9B
1.24 (1.06–1.44)
0.006
LYVE1
1.36 (1.07–1.72)
0.013
COX6A2
1.18 (1.05–1.32)
OXT
0.71 (0.61–0.83)
0.000